nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—Crohn's disease—ankylosing spondylitis	0.24	0.417	CtDrD
Sulfasalazine—ulcerative colitis—ankylosing spondylitis	0.17	0.295	CtDrD
Sulfasalazine—rheumatoid arthritis—ankylosing spondylitis	0.166	0.289	CtDrD
Sulfasalazine—PLA2G1B—Betamethasone—ankylosing spondylitis	0.129	0.38	CbGbCtD
Sulfasalazine—PLA2G1B—Dexamethasone—ankylosing spondylitis	0.075	0.221	CbGbCtD
Sulfasalazine—SLC46A1—Methotrexate—ankylosing spondylitis	0.0602	0.178	CbGbCtD
Sulfasalazine—TBXAS1—hip joint—ankylosing spondylitis	0.0239	0.424	CbGeAlD
Sulfasalazine—PTGS2—Triamcinolone—ankylosing spondylitis	0.0156	0.0459	CbGbCtD
Sulfasalazine—TBXAS1—hip—ankylosing spondylitis	0.0148	0.262	CbGeAlD
Sulfasalazine—PTGS2—Betamethasone—ankylosing spondylitis	0.0134	0.0394	CbGbCtD
Sulfasalazine—ABCC2—Dexamethasone—ankylosing spondylitis	0.00786	0.0232	CbGbCtD
Sulfasalazine—PTGS2—Dexamethasone—ankylosing spondylitis	0.00777	0.0229	CbGbCtD
Sulfasalazine—TBXAS1—knee—ankylosing spondylitis	0.00724	0.128	CbGeAlD
Sulfasalazine—SLCO1B1—Methotrexate—ankylosing spondylitis	0.00719	0.0212	CbGbCtD
Sulfasalazine—ABCG2—Dexamethasone—ankylosing spondylitis	0.00711	0.021	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—ankylosing spondylitis	0.00632	0.0186	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—ankylosing spondylitis	0.00571	0.0169	CbGbCtD
Sulfasalazine—TBXAS1—skeletal joint—ankylosing spondylitis	0.00519	0.0921	CbGeAlD
Sulfasalazine—CYP3A5—Dexamethasone—ankylosing spondylitis	0.00394	0.0116	CbGbCtD
Sulfasalazine—TBXAS1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00135	0.0496	CbGpPWpGaD
Sulfasalazine—PTGS2—skeletal joint—ankylosing spondylitis	0.001	0.0177	CbGeAlD
Sulfasalazine—PTGS2—synovial membrane of synovial joint—ankylosing spondylitis	0.00076	0.0135	CbGeAlD
Sulfasalazine—CHUK—IL1-mediated signaling events—IL1R2—ankylosing spondylitis	0.000725	0.0267	CbGpPWpGaD
Sulfasalazine—ACAT1—tendon—ankylosing spondylitis	0.000714	0.0127	CbGeAlD
Sulfasalazine—CHUK—NOD1/2 Signaling Pathway—CARD9—ankylosing spondylitis	0.000677	0.0249	CbGpPWpGaD
Sulfasalazine—PTGS2—cartilage tissue—ankylosing spondylitis	0.000672	0.0119	CbGeAlD
Sulfasalazine—IKBKB—IL1-mediated signaling events—IL1R2—ankylosing spondylitis	0.000658	0.0242	CbGpPWpGaD
Sulfasalazine—CHUK—Interleukin-1 signaling—IL1R2—ankylosing spondylitis	0.000637	0.0234	CbGpPWpGaD
Sulfasalazine—IKBKB—NOD1/2 Signaling Pathway—CARD9—ankylosing spondylitis	0.000614	0.0226	CbGpPWpGaD
Sulfasalazine—TBXAS1—tendon—ankylosing spondylitis	0.000597	0.0106	CbGeAlD
Sulfasalazine—IKBKB—Interleukin-1 signaling—IL1R2—ankylosing spondylitis	0.000578	0.0212	CbGpPWpGaD
Sulfasalazine—CHUK—NOD pathway—CARD9—ankylosing spondylitis	0.000541	0.0199	CbGpPWpGaD
Sulfasalazine—SLC46A1—tendon—ankylosing spondylitis	0.000532	0.00943	CbGeAlD
Sulfasalazine—IKBKB—NOD pathway—CARD9—ankylosing spondylitis	0.000491	0.018	CbGpPWpGaD
Sulfasalazine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.000462	0.017	CbGpPWpGaD
Sulfasalazine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.000419	0.0154	CbGpPWpGaD
Sulfasalazine—IKBKB—tendon—ankylosing spondylitis	0.000362	0.00641	CbGeAlD
Sulfasalazine—SLC46A1—Folate Metabolism—CRP—ankylosing spondylitis	0.000353	0.013	CbGpPWpGaD
Sulfasalazine—IKBKB—IL17 signaling pathway—IL17A—ankylosing spondylitis	0.000353	0.013	CbGpPWpGaD
Sulfasalazine—SLC46A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000348	0.0128	CbGpPWpGaD
Sulfasalazine—CHUK—IL1-mediated signaling events—IL1RN—ankylosing spondylitis	0.000343	0.0126	CbGpPWpGaD
Sulfasalazine—CHUK—TNF receptor signaling pathway —TNFRSF1B—ankylosing spondylitis	0.000318	0.0117	CbGpPWpGaD
Sulfasalazine—IKBKB—IL1-mediated signaling events—IL1RN—ankylosing spondylitis	0.000311	0.0114	CbGpPWpGaD
Sulfasalazine—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.000303	0.0111	CbGpPWpGaD
Sulfasalazine—CHUK—Interleukin-1 signaling—IL1RN—ankylosing spondylitis	0.000301	0.0111	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—IL1R2—ankylosing spondylitis	0.000299	0.011	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF receptor signaling pathway —TNFRSF1B—ankylosing spondylitis	0.000289	0.0106	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL1R2—ankylosing spondylitis	0.000288	0.0106	CbGpPWpGaD
Sulfasalazine—IKBKB—Interleukin-1 signaling—IL1RN—ankylosing spondylitis	0.000273	0.01	CbGpPWpGaD
Sulfasalazine—CHUK—Endogenous TLR signaling—TLR4—ankylosing spondylitis	0.000262	0.00961	CbGpPWpGaD
Sulfasalazine—CHUK—IKK complex recruitment mediated by RIP1—TLR4—ankylosing spondylitis	0.000262	0.00961	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL1R2—ankylosing spondylitis	0.000261	0.00959	CbGpPWpGaD
Sulfasalazine—SLC7A11—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000256	0.00942	CbGpPWpGaD
Sulfasalazine—CHUK—IL1-mediated signaling events—IL1A—ankylosing spondylitis	0.000247	0.00907	CbGpPWpGaD
Sulfasalazine—PTGS1—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000245	0.00902	CbGpPWpGaD
Sulfasalazine—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00024	0.00882	CbGpPWpGaD
Sulfasalazine—IKBKB—IKK complex recruitment mediated by RIP1—TLR4—ankylosing spondylitis	0.000237	0.00871	CbGpPWpGaD
Sulfasalazine—IKBKB—Endogenous TLR signaling—TLR4—ankylosing spondylitis	0.000237	0.00871	CbGpPWpGaD
Sulfasalazine—PPARG—tendon—ankylosing spondylitis	0.000225	0.00399	CbGeAlD
Sulfasalazine—IKBKB—IL1-mediated signaling events—IL1A—ankylosing spondylitis	0.000224	0.00823	CbGpPWpGaD
Sulfasalazine—CHUK—Interleukin-1 signaling—IL1A—ankylosing spondylitis	0.000217	0.00797	CbGpPWpGaD
Sulfasalazine—ABCC2—tendon—ankylosing spondylitis	0.000198	0.00351	CbGeAlD
Sulfasalazine—IKBKB—Interleukin-1 signaling—IL1A—ankylosing spondylitis	0.000197	0.00723	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000197	0.00722	CbGpPWpGaD
Sulfasalazine—PTGS2—Overview of nanoparticle effects—CRP—ankylosing spondylitis	0.000195	0.00716	CbGpPWpGaD
Sulfasalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000192	0.00706	CbGpPWpGaD
Sulfasalazine—CHUK—Structural Pathway of Interleukin 1 (IL-1)—IL1A—ankylosing spondylitis	0.000191	0.007	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.000183	0.00673	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000183	0.00672	CbGpPWpGaD
Sulfasalazine—CHUK—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.000182	0.0067	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000178	0.00655	CbGpPWpGaD
Sulfasalazine—CHUK—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000175	0.00643	CbGpPWpGaD
Sulfasalazine—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—IL1A—ankylosing spondylitis	0.000173	0.00635	CbGpPWpGaD
Sulfasalazine—CHUK—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000168	0.00618	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.000167	0.00614	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—CRP—ankylosing spondylitis	0.000166	0.0061	CbGpPWpGaD
Sulfasalazine—CHUK—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.000166	0.00609	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000166	0.00609	CbGpPWpGaD
Sulfasalazine—IKBKB—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.000165	0.00607	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—ankylosing spondylitis	0.000165	0.00607	CbGpPWpGaD
Sulfasalazine—SLC46A1—Folate Metabolism—TNF—ankylosing spondylitis	0.00016	0.00588	CbGpPWpGaD
Sulfasalazine—IKBKB—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000159	0.00583	CbGpPWpGaD
Sulfasalazine—IKBKB—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000152	0.0056	CbGpPWpGaD
Sulfasalazine—CHUK—TCR signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000152	0.00557	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.00015	0.00552	CbGpPWpGaD
Sulfasalazine—CHUK—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.000148	0.00545	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—ANTXR2—ankylosing spondylitis	0.000147	0.00541	CbGpPWpGaD
Sulfasalazine—PPARG—Transcription factor regulation in adipogenesis—TNF—ankylosing spondylitis	0.000141	0.00518	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000139	0.00512	CbGpPWpGaD
Sulfasalazine—PTGS2—Fluocinonide—Methylprednisolone—ankylosing spondylitis	0.000139	0.0716	CbGdCrCtD
Sulfasalazine—IKBKB—TCR signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000138	0.00506	CbGpPWpGaD
Sulfasalazine—PTGS2—Fluocinonide—Dexamethasone—ankylosing spondylitis	0.000137	0.0704	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Betamethasone—ankylosing spondylitis	0.000137	0.0704	CbGdCrCtD
Sulfasalazine—CHUK—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.000136	0.005	CbGpPWpGaD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.000134	0.00494	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000134	0.00493	CbGpPWpGaD
Sulfasalazine—PTGS2—Fluocinonide—Triamcinolone—ankylosing spondylitis	0.000134	0.0688	CbGdCrCtD
Sulfasalazine—CHUK—B Cell Receptor Signaling Pathway—CD79A—ankylosing spondylitis	0.00013	0.00478	CbGpPWpGaD
Sulfasalazine—CHUK—Canonical NF-kappaB pathway—TNF—ankylosing spondylitis	0.000128	0.00469	CbGpPWpGaD
Sulfasalazine—CHUK—EBV LMP1 signaling—TNF—ankylosing spondylitis	0.000128	0.00469	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000126	0.00465	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.000123	0.00453	CbGpPWpGaD
Sulfasalazine—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—ankylosing spondylitis	0.000123	0.00453	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000122	0.00447	CbGpPWpGaD
Sulfasalazine—PTGS1—tendon—ankylosing spondylitis	0.00012	0.00213	CbGeAlD
Sulfasalazine—IKBKB—Type II diabetes mellitus—TNF—ankylosing spondylitis	0.00012	0.00441	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000119	0.00439	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Receptor Signaling Pathway—CD79A—ankylosing spondylitis	0.000118	0.00434	CbGpPWpGaD
Sulfasalazine—IKBKB—EBV LMP1 signaling—TNF—ankylosing spondylitis	0.000116	0.00426	CbGpPWpGaD
Sulfasalazine—IKBKB—Canonical NF-kappaB pathway—TNF—ankylosing spondylitis	0.000116	0.00426	CbGpPWpGaD
Sulfasalazine—PTGS2—tendon—ankylosing spondylitis	0.000115	0.00204	CbGeAlD
Sulfasalazine—CHUK—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.000113	0.00417	CbGpPWpGaD
Sulfasalazine—SLC7A11—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000112	0.0578	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000112	0.0578	CbGdCrCtD
Sulfasalazine—PTGS1—Overview of nanoparticle effects—TNF—ankylosing spondylitis	0.000111	0.00408	CbGpPWpGaD
Sulfasalazine—SLC7A11—Betamethasone—Dexamethasone—ankylosing spondylitis	0.00011	0.0569	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Betamethasone—ankylosing spondylitis	0.00011	0.0569	CbGdCrCtD
Sulfasalazine—ACAT1—Metabolism—B3GNT2—ankylosing spondylitis	0.00011	0.00403	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000109	0.004	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000108	0.00398	CbGpPWpGaD
Sulfasalazine—SLC7A11—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000108	0.0556	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000108	0.0556	CbGdCrCtD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—ankylosing spondylitis	0.000107	0.00393	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000107	0.00392	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000106	0.00388	CbGpPWpGaD
Sulfasalazine—IKBKB—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.000103	0.00378	CbGpPWpGaD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisone—ankylosing spondylitis	0.000102	0.0527	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisone—ankylosing spondylitis	0.000102	0.0527	CbGdCrCtD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.0001	0.00368	CbGpPWpGaD
Sulfasalazine—SLC7A11—Betamethasone—Prednisolone—ankylosing spondylitis	9.99e-05	0.0515	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisolone—ankylosing spondylitis	9.99e-05	0.0515	CbGdCrCtD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	9.87e-05	0.00363	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by Interleukins—IL1A—ankylosing spondylitis	9.8e-05	0.0036	CbGpPWpGaD
Sulfasalazine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	9.57e-05	0.00352	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	9.28e-05	0.00341	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by Interleukins—IL1A—ankylosing spondylitis	8.88e-05	0.00326	CbGpPWpGaD
Sulfasalazine—PTGS2—Overview of nanoparticle effects—TNF—ankylosing spondylitis	8.82e-05	0.00324	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	8.77e-05	0.00322	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—B3GNT2—ankylosing spondylitis	8.68e-05	0.00319	CbGpPWpGaD
Sulfasalazine—CHUK—MyD88-independent cascade—TLR4—ankylosing spondylitis	8.42e-05	0.00309	CbGpPWpGaD
Sulfasalazine—PTGS2—Fluticasone Propionate—Methylprednisolone—ankylosing spondylitis	8.38e-05	0.0432	CbGdCrCtD
Sulfasalazine—TBXAS1—Metabolism—B3GNT2—ankylosing spondylitis	8.32e-05	0.00306	CbGpPWpGaD
Sulfasalazine—PTGS2—Fluticasone Propionate—Dexamethasone—ankylosing spondylitis	8.24e-05	0.0425	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Betamethasone—ankylosing spondylitis	8.24e-05	0.0425	CbGdCrCtD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	8.22e-05	0.00302	CbGpPWpGaD
Sulfasalazine—PTGS2—Fluticasone Propionate—Triamcinolone—ankylosing spondylitis	8.06e-05	0.0415	CbGdCrCtD
Sulfasalazine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	7.96e-05	0.00292	CbGpPWpGaD
Sulfasalazine—CHUK—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	7.89e-05	0.0029	CbGpPWpGaD
Sulfasalazine—IKBKB—MyD88-independent cascade—TLR4—ankylosing spondylitis	7.63e-05	0.0028	CbGpPWpGaD
Sulfasalazine—CHUK—Activated TLR4 signalling—TLR4—ankylosing spondylitis	7.57e-05	0.00278	CbGpPWpGaD
Sulfasalazine—ALOX5—Selenium Micronutrient Network—TNF—ankylosing spondylitis	7.52e-05	0.00276	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	7.45e-05	0.00274	CbGpPWpGaD
Sulfasalazine—CHUK—B Cell Activation—CD79A—ankylosing spondylitis	7.45e-05	0.00274	CbGpPWpGaD
Sulfasalazine—CHUK—TNF receptor signaling pathway —TNF—ankylosing spondylitis	7.34e-05	0.0027	CbGpPWpGaD
Sulfasalazine—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	7.31e-05	0.00269	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	7.31e-05	0.00269	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—B3GNT2—ankylosing spondylitis	7.27e-05	0.00267	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KIR3DL1—ankylosing spondylitis	7.24e-05	0.00266	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—CRP—ankylosing spondylitis	7.2e-05	0.00265	CbGpPWpGaD
Sulfasalazine—IKBKB—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	7.16e-05	0.00263	CbGpPWpGaD
Sulfasalazine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	7.12e-05	0.00262	CbGpPWpGaD
Sulfasalazine—IKBKB—Activated TLR4 signalling—TLR4—ankylosing spondylitis	6.87e-05	0.00252	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ERAP1—ankylosing spondylitis	6.86e-05	0.00252	CbGpPWpGaD
Sulfasalazine—IKBKB—B Cell Activation—CD79A—ankylosing spondylitis	6.75e-05	0.00248	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF receptor signaling pathway —TNF—ankylosing spondylitis	6.65e-05	0.00244	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	6.63e-05	0.00244	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KIR3DL1—ankylosing spondylitis	6.56e-05	0.00241	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CARD9—ankylosing spondylitis	6.53e-05	0.0024	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	6.46e-05	0.00237	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	6.42e-05	0.00236	CbGpPWpGaD
Sulfasalazine—CHUK—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	6.36e-05	0.00234	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	6.35e-05	0.00233	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	6.34e-05	0.00233	CbGpPWpGaD
Sulfasalazine—CHUK—DAP12 interactions—HLA-B—ankylosing spondylitis	6.24e-05	0.00229	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	6.24e-05	0.00229	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ERAP1—ankylosing spondylitis	6.22e-05	0.00228	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—B3GNT2—ankylosing spondylitis	6.07e-05	0.00223	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CARD9—ankylosing spondylitis	5.92e-05	0.00218	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	5.82e-05	0.00214	CbGpPWpGaD
Sulfasalazine—IKBKB—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	5.77e-05	0.00212	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	5.76e-05	0.00212	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	5.75e-05	0.00211	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—CRP—ankylosing spondylitis	5.71e-05	0.0021	CbGpPWpGaD
Sulfasalazine—PPARG—Signaling events mediated by HDAC Class I—TNF—ankylosing spondylitis	5.59e-05	0.00205	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—IL1A—ankylosing spondylitis	5.41e-05	0.00199	CbGpPWpGaD
Sulfasalazine—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—ankylosing spondylitis	5.18e-05	0.0019	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ANTXR2—ankylosing spondylitis	5.07e-05	0.00186	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	4.57e-05	0.00168	CbGpPWpGaD
Sulfasalazine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	4.53e-05	0.00167	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TNF—ankylosing spondylitis	4.53e-05	0.00167	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1R2—ankylosing spondylitis	4.39e-05	0.00161	CbGpPWpGaD
Sulfasalazine—PTGS2—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	4.35e-05	0.0016	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TLR4—ankylosing spondylitis	4.33e-05	0.00159	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	4.32e-05	0.00159	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—B3GNT2—ankylosing spondylitis	4.3e-05	0.00158	CbGpPWpGaD
Sulfasalazine—CHUK—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	4.21e-05	0.00155	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ERAP1—ankylosing spondylitis	4.16e-05	0.00153	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	4.15e-05	0.00152	CbGpPWpGaD
Sulfasalazine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	4.11e-05	0.00151	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TNF—ankylosing spondylitis	4.11e-05	0.00151	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HLA-C—ankylosing spondylitis	4.1e-05	0.00151	CbGpPWpGaD
Sulfasalazine—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ankylosing spondylitis	4.07e-05	0.00149	CbGpPWpGaD
Sulfasalazine—CHUK—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	4.01e-05	0.00147	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1R2—ankylosing spondylitis	3.98e-05	0.00146	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-C—ankylosing spondylitis	3.94e-05	0.00145	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	3.92e-05	0.00144	CbGpPWpGaD
Sulfasalazine—CHUK—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	3.88e-05	0.00143	CbGpPWpGaD
Sulfasalazine—IKBKB—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	3.82e-05	0.0014	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CARD9—ankylosing spondylitis	3.8e-05	0.0014	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ERAP1—ankylosing spondylitis	3.77e-05	0.00139	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HLA-C—ankylosing spondylitis	3.72e-05	0.00137	CbGpPWpGaD
Sulfasalazine—IKBKB—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	3.63e-05	0.00133	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-C—ankylosing spondylitis	3.57e-05	0.00131	CbGpPWpGaD
Sulfasalazine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	3.52e-05	0.00129	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—HLA-A—ankylosing spondylitis	3.51e-05	0.00129	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CARD9—ankylosing spondylitis	3.45e-05	0.00127	CbGpPWpGaD
Sulfasalazine—PPARG—Adipogenesis—TNF—ankylosing spondylitis	3.4e-05	0.00125	CbGpPWpGaD
Sulfasalazine—PTGS1—Selenium Micronutrient Network—TNF—ankylosing spondylitis	3.26e-05	0.0012	CbGpPWpGaD
Sulfasalazine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	3.03e-05	0.00111	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD79A—ankylosing spondylitis	3e-05	0.0011	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ANTXR2—ankylosing spondylitis	3e-05	0.0011	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—B3GNT2—ankylosing spondylitis	2.99e-05	0.0011	CbGpPWpGaD
Sulfasalazine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	2.75e-05	0.00101	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD79A—ankylosing spondylitis	2.72e-05	0.001	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—B3GNT2—ankylosing spondylitis	2.66e-05	0.000979	CbGpPWpGaD
Sulfasalazine—PTGS2—Selenium Micronutrient Network—TNF—ankylosing spondylitis	2.59e-05	0.000951	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD40LG—ankylosing spondylitis	2.45e-05	0.000899	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—HLA-B—ankylosing spondylitis	2.42e-05	0.000891	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-C—ankylosing spondylitis	2.39e-05	0.000878	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TNF—ankylosing spondylitis	2.36e-05	0.000867	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	2.35e-05	0.000863	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-B—ankylosing spondylitis	2.33e-05	0.000856	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD40LG—ankylosing spondylitis	2.22e-05	0.000816	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—HLA-B—ankylosing spondylitis	2.2e-05	0.000808	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-C—ankylosing spondylitis	2.17e-05	0.000796	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—HLA-A—ankylosing spondylitis	2.16e-05	0.000793	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CRP—ankylosing spondylitis	2.14e-05	0.000788	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-B—ankylosing spondylitis	2.11e-05	0.000776	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—B3GNT2—ankylosing spondylitis	2.1e-05	0.000771	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1RN—ankylosing spondylitis	2.07e-05	0.000762	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—TLR4—ankylosing spondylitis	2.05e-05	0.000755	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TNF—ankylosing spondylitis	2.05e-05	0.000752	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HLA-A—ankylosing spondylitis	1.96e-05	0.000719	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CRP—ankylosing spondylitis	1.94e-05	0.000714	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—B3GNT2—ankylosing spondylitis	1.94e-05	0.000714	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1RN—ankylosing spondylitis	1.88e-05	0.000691	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—B3GNT2—ankylosing spondylitis	1.87e-05	0.000686	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—TLR4—ankylosing spondylitis	1.86e-05	0.000685	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD79A—ankylosing spondylitis	1.82e-05	0.000669	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—B3GNT2—ankylosing spondylitis	1.77e-05	0.00065	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD79A—ankylosing spondylitis	1.65e-05	0.000607	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL1A—ankylosing spondylitis	1.49e-05	0.000549	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40LG—ankylosing spondylitis	1.48e-05	0.000546	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—B3GNT2—ankylosing spondylitis	1.48e-05	0.000544	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTGER4—ankylosing spondylitis	1.43e-05	0.000527	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-B—ankylosing spondylitis	1.41e-05	0.000519	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	1.39e-05	0.000511	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—B3GNT2—ankylosing spondylitis	1.39e-05	0.000511	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1A—ankylosing spondylitis	1.35e-05	0.000498	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40LG—ankylosing spondylitis	1.35e-05	0.000495	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HLA-A—ankylosing spondylitis	1.31e-05	0.000481	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTGER4—ankylosing spondylitis	1.3e-05	0.000478	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-B—ankylosing spondylitis	1.28e-05	0.000471	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CRP—ankylosing spondylitis	1.25e-05	0.000459	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HLA-A—ankylosing spondylitis	1.21e-05	0.000444	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—TLR4—ankylosing spondylitis	1.2e-05	0.00044	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HLA-A—ankylosing spondylitis	1.19e-05	0.000436	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—TNF—ankylosing spondylitis	1.17e-05	0.00043	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CRP—ankylosing spondylitis	1.13e-05	0.000416	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—TLR4—ankylosing spondylitis	1.09e-05	0.000399	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP3—ankylosing spondylitis	1.02e-05	0.000375	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP3—ankylosing spondylitis	9.26e-06	0.00034	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HLA-A—ankylosing spondylitis	7.16e-06	0.000263	CbGpPWpGaD
